Aesthetic manufacturers can now receive consulting and advice for hyaluronic acid and chitosan products with the launch of Falgagen.
Following positive phase 2 results from its ready-to-use liquid formulation botulinum toxin, global pharmaceutical company Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden.
Compounding pharmacy Roseway Labs is now distributing supplements from Pure Encapsulations and Thorne Research.
The British Skin Foundation, a charity dedicated to raising funds for skin disease research, has conducted a survey amongst 245 dermatologists indicating that 87% believe that there is a lack of access to psychological support for those suffering with skin conditions in the UK.
On September 16, Lynton customers were invited to attend a workshop hosted at the Hilton Hotel in Deansgate, Manchester to meet with the company’s staff and discuss the latest innovation in the aesthetics industry.
Medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota).
A plant-derived solution named Fraxin has been launched into the aesthetics market aiming to address signs of ageing.
Aesthetic distributor AestheticSource has announced that the topical designed to treat pigmentation, currently known as Cysteamine Cream, has rebranded to Cyspera.
Following a soft launch at the Aesthetics Conference and Exhibition earlier this year, online platform Fvce will be officially released at CCR on October 10-11.
A study has suggested that retrobulbar hyaluronidase injection is unlikely to alleviate vision loss caused by hyaluronic acid (HA) filler injections.